Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chae Yoon Chon

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Pharmacogenetics and Genomics|May 16, 2007
MRP2 haplotypes confer differential susceptibility to toxic liver injuryJi Ha Choi, Byung Min Ahn, Jihyun Yi, et al.
Cell Transplantation|June 8, 2010
Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosisJa Kyung Kim, Young Nyun Park, Jin Seok Kim, et al.
Journal of Gastroenterology|December 25, 2010
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, et al.
Hepatology (Baltimore, Md.)|July 25, 2007
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionByung Chul Yoo, Ju Hyun Kim, Tae-Hun Kim, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis BByung Chul Yoo, Ju Hyun Kim, Young-Hwa Chung, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Pharmacogenetics and Genomics|May 16, 2007
MRP2 haplotypes confer differential susceptibility to toxic liver injuryJi Ha Choi, Byung Min Ahn, Jihyun Yi, et al.
Cell Transplantation|June 8, 2010
Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosisJa Kyung Kim, Young Nyun Park, Jin Seok Kim, et al.
Journal of Gastroenterology|December 25, 2010
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, et al.
Hepatology (Baltimore, Md.)|July 25, 2007
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionByung Chul Yoo, Ju Hyun Kim, Tae-Hun Kim, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis BByung Chul Yoo, Ju Hyun Kim, Young-Hwa Chung, et al.
Pageof 16